ArticleBMC surgery2025
Risk assessment of hyperbilirubinemia using a three-factor model after cardiac surgery.
Article in BMC surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Factors influencing postoperative hyperbilirubinemia in valvular heart disease and establishment of a predictive model.Frontiers in cardiovascular medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHyperbilirubinemia (HB) is a common occurrence after cardiopulmonary bypass and often results in increased rates of complications.
methodsWe conducted a study on 411 patients who underwent cardiac surgery with extracorporeal circulation and divided them into a training set and a validation set. Least absolute shrinkage and selection operator (LASSO) regression was employed to screen out variables. Multivariate logistic regression was subsequently applied to establish prediction models, which were then evaluated using receiver operating characteristic (ROC) curves and calibration plots. Finally, restricted cubic splines (RCSs) curve pairs were used to calculate the adjusted ORs for each independent risk factor.
resultsA clinical prediction model based on preoperative bilirubin elevation, aortic clamp time and intraoperative red blood cell (RBC) transfusion was successfully developed. The model presented an ROC of 0.855 (0.808, 0.901) in the training set. The validation set demonstrated a promising ROC of 0.839 (0.761, 0.917), and the calibration curve closely approximated the true incidence. The risk of postoperative HB was increased when the aortic clamp time was greater than 133 min, when the red blood transfusion volume was greater than 275 ml or when the preoperative total bilirubin concentration was greater than 16.65 mol/L.
conclusionIn this study, the aortic clamp time was identified as a crucial factor for postoperative HB during cardiac surgery. A three-factor prediction model that includes the aortic clamp time for the prediction of HB after cardiac surgery was successfully established. Furthermore, patients with hyperbilirubinemia post-surgery had a worse short-term prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.